Open AccessInduction of ovarian steroidogenesis as an additional potential risk factor for progression in premenopausal patients with hormone-receptor-positive breast cancer receiving tamoxifen as adjuvant therapy
Author(s) -
A. Yu. Goryainova,
А. I. Stukan,
Е. V. Lymar,
Z. K. Khachmamuk,
И. Г. Селезнева
Publication year - 2022
Publication title -
medicinskij sovet
Language(s) - English
Resource type - Journals
eISSN - 2658-5790
pISSN - 2079-701X
DOI - 10.21518/2079-701x-2022-16-9-131-138
Subject(s) - medicine , tamoxifen , breast cancer , amenorrhea , cohort , gynecology , follicular phase , oncology , chemotherapy , endocrinology , cancer , gastroenterology , pregnancy , biology , genetics